Should I buy or sell Opsens stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Opsens in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" OPS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OPS, but not buy additional shares or sell existing shares. View OPS analyst ratings or view top-rated stocks .

What is Opsens' stock price target for 2024?

1 equities research analysts have issued 12-month price objectives for Opsens' shares. Their OPS share price targets range from C$2.90 to C$2.90. On average, they anticipate the company's share price to reach C$2.90 in the next twelve months. View analysts price targets for OPS or view top-rated stocks among Wall Street analysts .

How were Opsens' earnings last quarter?

Opsens Inc. (TSE:OPS) issued its earnings results on Thursday, June, 29th. The company reported ($0.02) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.02). The company earned $4.89 million during the quarter. Opsens had a negative net margin of 25.65% and a negative trailing twelve-month return on equity of 36.43%.

What other stocks do shareholders of Opsens own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Opsens investors own include Acadian Timber (ADN) , Agellan Commercial Real Estate Invtmt TR (ACR.UN) , AutoCanada (ACQ) , ATCO (ACO.X) , Accord Financial (ACD) , Aurora Cannabis (ACB) , Air Canada (AC) , Barrick Gold (ABX) and Absolute Software Co. (ABT.TO) (ABT) .

How do I buy shares of Opsens?

Shares of OPS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

TSE:OPS

Opsens (OPS) Stock Price, News & Analysis

→ Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad)

Free OPS Stock Alerts

Compare

Today's Range: N/A
50-Day Range: C$2.84
▼
C$2.90
52-Week Range: N/A

Volume: 49,783 shs
Average Volume: 112,402 shs
Market Capitalization: C$335.47 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: C$2.90

Stock Analysis Analyst Forecasts Chart Earnings Headlines Insider Trades

Get Opsens alerts:

Ad DTI

This company has increased its dividend every year for 54 years

There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.

Click here to get them (for Free).

About Opsens Stock (TSE:OPS)

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for cardiovascular interventions. The company operates in two segments, Medical and Industrial. The company provides advanced optical-based pressure guidewire (OptoWire), a guidewire used in the transcatheter aortic valve replacement procedure; and a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated in other medical devices. It also develops, manufactures, and markets medical products; and offers OPP-GD fiber optic differential pressure sensors and the OEC fiber optic extensometer sensors. The company serves life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and various other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. Opsens Inc. was formerly known as Capital DCB inc. and changed its name to OpSens Inc. in October 2006. The company was founded in 2003 and is headquartered in Québec, Canada. As of December 12, 2023, Opsens Inc. operates as a subsidiary of Haemonetics Corporation.

Ad The Bull Report

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

OPS Stock News Headlines

April 12, 2024 | markets.businessinsider.com

Haemonetics Poised for Growth with Strong Q4 Projections and Strategic Acquisitions

March 6, 2024 | seekingalpha.com

Haemonetics Corporation: Improved Performance, Another Bolt-On Deal

April 19, 2024 | Priority Gold (Ad)

Biden to Launch “FedNOW” [Move Your Money Now]

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

February 9, 2024 | finance.yahoo.com

Haemonetics Corporation (NYSE:HAE) Q3 2024 Earnings Call Transcript

February 3, 2024 | theglobeandmail.com

Closing Bell: Opsens Inc flat on Wednesday (OPS)

December 8, 2023 | finance.yahoo.com

OPSENS RECEIVES FINAL ORDER FOR ARRANGEMENT WITH HAEMONETICS

December 1, 2023 | finance.yahoo.com

OPSENS' SHAREHOLDERS APPROVE ARRANGEMENT WITH HAEMONETICS

November 28, 2023 | ca.finance.yahoo.com

Hill, Opsens, Thinkific at 52-Week High on News

April 19, 2024 | Priority Gold (Ad)

Biden to Launch “FedNOW” [Move Your Money Now]

November 28, 2023 | finance.yahoo.com

OPSENS OBTAINS REGULATORY CLEARANCE OF ARRANGEMENT IN THE UNITED STATES AND CANADA; REGULATORY APPROVALS CONDITION SATISFIED

November 28, 2023 | theglobeandmail.com

Opsens: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (OPS)

November 22, 2023 | msn.com

Opsens GAAP EPS of -C$0.01, revenue of C$14.11M

November 22, 2023 | finance.yahoo.com

OPSENS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS

November 13, 2023 | finance.yahoo.com

INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS SHAREHOLDERS VOTE "FOR" OPSENS INC. PLAN OF ARRANGEMENT WITH HAEMONETICS CORPORATION

November 5, 2023 | morningstar.com

Opsens Inc OPS

October 14, 2023 | theglobeandmail.com

Closing Bell: Opsens Inc flat on Friday (OPS)

October 12, 2023 | theglobeandmail.com

Closing Bell: Opsens Inc flat on Thursday (OPS)

October 11, 2023 | markets.businessinsider.com

RBC Capital Believes Opsens Inc (OPS) Won’t Stop Here

October 10, 2023 | marketwatch.com

Opsens Shares Climb on C$345M Deal to be Acquired by Haemonetics

October 5, 2023 | msn.com

Opsens (OPSSF) Price Target Increased by 6.28% to 2.77

August 21, 2023 | cnbc.com

RBC names the Canadian stocks set to ‘materially outperform’ in the next 12 months — here are 8 on its conviction list

August 8, 2023 | markets.businessinsider.com

Nyra Medical names Lori Chmura as Chief Executive Officer

July 14, 2023 | markets.businessinsider.com

Opsens Inc (OPS) Receives a Buy from RBC Capital

July 13, 2023 | finance.yahoo.com

Morning News Call - Canada, July 13

July 13, 2023 | marketwatch.com

Opsens 3Q Loss Widens as Sales, Marketing Costs Rise, Revenue Tops Views

July 13, 2023 | finance.yahoo.com

OPSENS ANNOUNCES A THIRD CONSECUTIVE QUARTER OF RECORD REVENUES FOR THIRD QUARTER FISCAL 2023

July 12, 2023 | markets.businessinsider.com

Opsens is about to announce its earnings — here's what Wall Street expects

See More Headlines

Receive OPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Opsens and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 6/29/2017
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: TSE
Sector: Medical
Industry: Medical Instruments & Supplies
Sub-Industry: N/A
Current Symbol: TSE:OPS
CUSIP: N/A
CIK: N/A
Web: opsens.com
Phone: 418-781-0333
Fax: N/A
Employees: 293
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: C$2.90
High Stock Price Target: C$2.90
Low Stock Price Target: C$2.90
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): C($0.11)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-12,400,000.00
Net Margins: -25.65%
Pretax Margin: N/A
Return on Equity: -36.43%
Return on Assets: -15.76%

Debt

Debt-to-Equity Ratio: 27.22
Current Ratio: 4.42
Quick Ratio: 3.56

Sales & Book Value

Annual Sales: C$48.35 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 8.68
Book Value: C$0.29 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 115,680,000
Free Float: N/A
Market Cap: C$335.47 million
Optionable: Not Optionable
Beta: 0.32

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Mr. Alan W. Milinazzo (Age 63)
Executive Chairman of the Board
Comp: $99.2k
Mr. Louis Laflamme C.A.
CPA, CPA, CEO, President & Director
Mr. Brad Davis
Chief Commercial Officer
Mr. John Hannigan
Chief Financial Officer
Mr. Pierre Poulin
Corporate Controller

Key Competitors

View All Competitors

OPS Stock Analysis - Frequently Asked Questions

Should I buy or sell Opsens stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Opsens in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" OPS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OPS, but not buy additional shares or sell existing shares.
View OPS analyst ratings or view top-rated stocks.
What is Opsens' stock price target for 2024?: 1 equities research analysts have issued 12-month price objectives for Opsens' shares. Their OPS share price targets range from C$2.90 to C$2.90. On average, they anticipate the company's share price to reach C$2.90 in the next twelve months.
View analysts price targets for OPS or view top-rated stocks among Wall Street analysts.
How were Opsens' earnings last quarter?: Opsens Inc. (TSE:OPS) issued its earnings results on Thursday, June, 29th. The company reported ($0.02) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.02). The company earned $4.89 million during the quarter. Opsens had a negative net margin of 25.65% and a negative trailing twelve-month return on equity of 36.43%.

What other stocks do shareholders of Opsens own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Opsens investors own include Acadian Timber (ADN), Agellan Commercial Real Estate Invtmt TR (ACR.UN), AutoCanada (ACQ), ATCO (ACO.X), Accord Financial (ACD), Aurora Cannabis (ACB), Air Canada (AC), Barrick Gold (ABX) and Absolute Software Co. (ABT.TO) (ABT).
How do I buy shares of Opsens?: Shares of OPS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:OPS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial